Evidence map›Paper›PMID 17222505›Full record

ReviewMolecular and cellular endocrinology2007

GPR30: A G protein-coupled receptor for estrogen.

Eric R Prossnitz, Jeffrey B Arterburn, Larry A Sklar

Abstract readReview
In one paragraph

Review in Molecular and cellular endocrinology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eric R ProssnitzDepartment of Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131, United States. eprossnitz@salud.unm.edu
Jeffrey B Arterburn
Larry A Sklar

Funding

New Mexico Molecular Libraries Screening Center(RMI)U54MH074425 · NIMH · UNIVERSITY OF NEW MEXICO · PI SKLAR, LARRY A. · 2005 to 2008
$10.0M
7TMR DRUG DISCOVERY, MICROFLUIDICS &HT FLOW CYTOMETRYR24EB000264 · NIBIB · UNIVERSITY OF NEW MEXICO · PI SKLAR, LARRY A. · 2002 to 2003
$1.5M
A novel intracellular 7TM estrogen receptor in breastR01CA116662 · NCI · UNIVERSITY OF NEW MEXICO · PI PROSSNITZ, ERIC R · 2006 to 2010
$1.3M
NCI NIH HHS CA116662NCI NIH HHS R01 CA116662NIBIB NIH HHS EB00264NIBIB NIH HHS R24 EB000264NIMH NIH HHS MH074425NIMH NIH HHS U54 MH074425
6 · The paper itself

Abstract

Estrogen is a critical steroid in human physiology exerting its effect both at the transcriptional level as well as at the level of rapid intracellular signaling through second messengers. Many of estrogen's transcriptional effects have long been known to be mediated through classical nuclear steroid receptors but recent studies also demonstrate the existence of a 7-transmembrane G protein-coupled receptor, GPR30 that responds to estrogen with rapid cellular signaling. There is currently controversy over the ability of classical estrogen receptors to recapitulate GPR30-mediated signaling mechanisms and vice versa. This article will summarize recent literature and address the relationship between GPR30 and conventional estrogen receptor signaling.

Indexed as

Signal TransductionEstrogensHumansLigandsReceptors, EstrogenReceptors, G-Protein-CoupledEstrogensGPER1 protein, humanLigandsReceptors, EstrogenReceptors, G-Protein-Coupled

Identifiers

PMID17222505
PMCPMC1847610

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.